Try the brand new Migraine eDiary app today.  Advertisement


To view an online version, [~ViewInBrowser~]click here[~EndViewInBrowser~].
To make sure you receive e-mails from RELPAX® (eletriptan HBr): please add to your address book.


RELPAX (R)(eletriptan HBr)
smartphones Summer–a time
to try new things.


Why not start with the
Migraine eDiary app?*


Download the Migraine eDiary app to start tracking your migraine experience.


APPLE app store    GOOGLE play

When planning all the things you want to try this summer, add the brand new Migraine eDiary smartphone app, brought to you by RELPAX, to your list.

With the Migraine eDiary app, you can monitor your migraine episodes by tracking your triggers, symptoms and treatment experience, anytime, anywhere.

You can also use the Migraine eDiary app to create personalized migraine reports. These reports can be shared with your doctor to enhance conversations about your migraine patterns and treatments.



When meeting with your doctor, remember to ask if RELPAX is right for you. If it is, you may be able to save up to $1200 per year on your prescription with the RELPAX $10 Co-pay Card. This may make the cost of RELPAX less than that of a generic triptan. This does not imply comparable safety, efficacy, or indications. Terms and Conditions apply.


  Take a fresh look at understanding your migraines with the Migraine eDiary app this summer!  


Do not take RELPAX® (eletriptan HBr) if you:
•  Have heart disease or a history of heart disease


•  Have a history of stroke, transient ischemic attack


•  Have a history or current evidence of hemiplegic or basilar migraines (if you are not sure about this, ask your doctor)


•  Have peripheral vascular disease (e.g. narrowing of blood vessels to the legs, arms, stomach, intestines, or kidneys)


•  Have ischemic bowel disease (inadequate blood supply to the intestine)


•  Have uncontrolled blood pressure


•  Have taken other migraine medications in the last 24 hours, including other triptans, ergots, or ergot-type medications


•  Are allergic to RELPAX or any of its ingredients


•  RELPAX should not be used within at least 72 hours of treatment with the following medicines: Nizoral® (ketoconazole), Sporanox® (itraconazole), Serzone® (nefazodone), TAO® (troleandomycin), Biaxin® (clarithromycin), Norvir® (ritonavir), and Viracept® (nelfinavir)
  All brands are trademarks of their owners.


Patients taking RELPAX may experience serious side effects, including:


Heart attacks and other heart problems. Heart problems may lead to death. Stop taking RELPAX and get emergency medical help right away if you have any symptoms of heart attack
like discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back; chest pain or chest discomfort that feels like an uncomfortable heavy pressure; squeezing, fullness, or pain; pain or discomfort in your arms, back, neck, jaw, or stomach; shortness of breath with or without chest discomfort; breaking out in a cold sweat; nausea or vomiting; feeling lightheaded.


Medication overuse headaches. Some patients who take too many RELPAX may have worse headaches. If your headaches get worse your doctor may decide to stop your treatment with RELPAX.


Serotonin syndrome is a serious and life-threatening problem that can happen when taking RELPAX, especially when used with certain medications commonly used to treat depression such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). Tell your doctor right away if you experience mental changes such as hallucinations, fast heartbeat, high body temperature, trouble walking, or nausea, vomiting or diarrhea.


Changes in color or sensation in your fingers and toes (Raynaud’s syndrome).


Stomach and intestinal problems
like sudden or severe stomach pain, stomach pain after meals, weight loss, nausea or vomiting, constipation or diarrhea, bloody diarrhea, fever.


Problems with blood circulation to your legs and feet (cramping and pain in your legs or hips); like feeling of heaviness or tightness in your leg muscles, burning or aching in your feet or toes while resting, numbness, tingling, or weakness in your legs, cold feeling or color changes in 1 or both legs or feet.


Most common side effects are dizziness, nausea, weakness, tiredness and drowsiness. If you have these symptoms, do not drive a car or do anything where you need to be alert. Tell your doctor about any side effects you have.


RELPAX should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.


RELPAX (eletriptan HBr) is indicated for the acute treatment of migraine with or without aura in adults. RELPAX should only be used where a clear diagnosis of migraine has been established. RELPAX is not for the prevention of migraines or other types of headaches, including cluster headache.


Click here for full Prescribing Information and Patient Information for RELPAX.


You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit, or call 1-800-FDA-1088.
  Need help paying for your Pfizermedicines?  
 * This app is for guidance purposes only. Both the report and the content within this application are for personal use to aid in a discussion with your doctor and are not intended for self-diagnosis. The information contained here is not a substitute for medical diagnosis or professional treatment. Pfizer makes no representation that the treatments you are taking are appropriate for your migraines. You should consult your doctor about your diagnosis and any treatment options.


  For emergency situations relating to your condition or medication taken, you should contact your doctor or call 911.


  Terms and Conditions apply. This Co-pay Card is not health insurance and is only accepted at participating pharmacies. Savings limited to $100 per month for 12 uses. Card may be used once per month. For help with the RELPAX $10 Co-pay Card, call 1-800-926-5334, or write: Pfizer, ATTN: RELPAX, PO Box 2225, Morrisville, PA 19067-8025.


  According to IMS data from January 2015, the average co-pay for generic triptans on commercial health plans is $9.76-$19.65.


The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.


The information provided in this e-mail is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.


Please do not reply, as this is an unattended e-mail inbox.
If you wish to contact Pfizer, click here, or write:


Pfizer, Attn: RELPAX
P.O. Box 29387
Mission, KS 66201-5387
Pfizer Logo


 © 2015 Pfizer Inc.  All rights reserved.   RSE735824-01
RELPAX (R) (eletiptran HBr) logo
  Terms of Use  |  Privacy Policy  |  Contact Us